Cubist Systematic Strategies, LLC Acadia Pharmaceuticals Inc Transaction History

Cubist Systematic Strategies, LLC

$15.6 Billion
Q1 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 523,029 shares of ACAD stock, worth $11.2 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

523,029

Previous 634,520 17.57%

Holding current value

$11.2 Million

Previous $11.6 Million 25.39%

% of portfolio

0.06%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$16.61 - $20.29 $1.85 Million - $2.26 Million	-111,491 Reduced 17.57%	523,029 $8.69 Million
Q4 2024 Feb 14, 2025	BUY	$14.29 - $18.76 $9.07 Million - $11.9 Million	634,520 New	634,520 $11.6 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $3.14 Million - $3.96 Million	215,060 Added 47.63%	666,578 $10.8 Million
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $1.18 Million - $2.05 Million	66,273 Added 17.2%	451,518 $8.35 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $8.01 Million - $12.2 Million	385,245 New	385,245 $12.1 Million
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $2.67 Million - $3.85 Million	-150,109 Reduced 56.82%	114,062 $2.73 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $4.13 Million - $5.3 Million	253,282 Added 2326.04%	264,171 $4.97 Million
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $1.31 Million - $1.71 Million	-91,936 Reduced 89.41%	10,889 $173,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $1.06 Million - $1.37 Million	74,952 Added 268.91%	102,825 $1.68 Million
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $1.42 Million - $2.97 Million	-109,010 Reduced 79.64%	27,873 $393,000
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $1.93 Million - $2.53 Million	92,063 Added 205.41%	136,883 $3.32 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $1.48 Million - $2.39 Million	-88,106 Reduced 66.28%	44,820 $1.05 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $870,424 - $1.37 Million	55,160 Added 70.93%	132,926 $2.21 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $643,129 - $909,000	33,151 Added 74.3%	77,766 $1.9 Million
Q1 2021 May 17, 2021	SELL	$25.02 - $54.99 $1.4 Million - $3.08 Million	-55,993 Reduced 55.65%	44,615 $1.15 Million
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $3.2 Million - $4.42 Million	77,896 Added 342.97%	100,608 $5.38 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $8.83 Million - $13.8 Million	-242,534 Reduced 91.44%	22,712 $937,000
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $10.4 Million - $14 Million	265,246 New	265,246 $12.9 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $1.12 Million - $1.66 Million	-35,348 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $2.24 Million - $3.18 Million	-61,828 Reduced 63.62%	35,348 $1.51 Million
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $2 Million - $3.96 Million	89,913 Added 1237.96%	97,176 $3.5 Million
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $2.61 Million - $3.14 Million	-111,762 Reduced 93.9%	7,263 $194,000
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $1.84 Million - $3.11 Million	113,647 Added 2113.18%	119,025 $3.2 Million
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $323,145 - $517,212	-22,566 Reduced 80.75%	5,378 $87,000
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $22,294 - $37,316	-1,711 Reduced 5.77%	27,944 $580,000
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $287,731 - $426,537	19,093 Added 180.77%	29,655 $453,000
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $121,248 - $174,452	5,396 Added 104.45%	10,562 $237,000
Q4 2017 Feb 14, 2018	SELL	$26.84 - $39.14 $118,418 - $172,685	-4,412 Reduced 46.06%	5,166 $156,000
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $282,455 - $367,507	9,578	9,578 $361,000

Others Institutions Holding ACAD

# of Institutions

351

Shares Held

165M

Call Options Held

1.77M

Put Options Held

307K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.45B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Acadia Pharmaceuticals Inc Transaction History